E-LIB Suche - Ergebnisse für: Zettl, U. K.

1

Immunopathology and Pathogenesis:

, In: Fatigue in Multiple Sclerosis,

Zettl, U. K. ; Patejdl, R. - p. 41-55 , 2023

Link: https://doi.org/10.1007/..

2

Multiple Sklerose und Hepatitis-B-Impfung: Was bedeutet das..:

Löbermann, M. ; Handorn, B. ; Winkelmann, A....
Der Nervenarzt. 89 (2018) 10 - p. 1172-1178 , 2018

Link: https://doi.org/10.1007/..

3

The sphingosine analog fingolimod (FTY720) enhances tone an..:

Kraft, M. ; Zettl, U. K. ; Noack, T..
Neurogastroenterology & Motility. 30 (2018) 10 - p. , 2018

Link: https://doi.org/10.1111/..

4

Neuromyelitis optica spectrum disorder coinciding with hema..:

Patejdl, R. ; Wittstock, M. ; Zettl, U.K....
Multiple Sclerosis and Related Disorders. 9 (2016) - p. 101-103 , 2016

Link: https://doi.org/10.1016/..

5

Coping with multiple sclerosis-the role of social support:

Rommer, P. S. ; Sühnel, A. ; König, N..
Acta Neurologica Scandinavica. 136 (2016) 1 - p. 11-16 , 2016

Link: https://doi.org/10.1111/..

6

Symptomatic treatment in multiple sclerosis-interim analysi..:

Skierlo, S. ; Rommer, P. S. ; Zettl, U. K.
Acta Neurologica Scandinavica. 135 (2016) 4 - p. 394-399 , 2016

Link: https://doi.org/10.1111/..

7

Baseline predictors of persistence to first disease-modifyi..:

Zettl, U. K. ; Schreiber, H. ; Bauer-Steinhusen, U....
Acta Neurologica Scandinavica. 136 (2016) 2 - p. 116-121 , 2016

Link: https://doi.org/10.1111/..

8

Safety and Clinical Outcomes of Rituximab Treatment in Pati..:

GRAID investigators ; Rommer, P. S. ; Dörner, T....
Journal of Neuroimmune Pharmacology. 11 (2015) 1 - p. 1-8 , 2015

Link: https://doi.org/10.1007/..

9

Immuntherapien und infektiologische Probleme bei Multipler ..:

Winkelmann, A. ; Löbermann, M. ; Reisinger, E.C...
Der Nervenarzt. 86 (2015) 8 - p. 960-970 , 2015

Link: https://doi.org/10.1007/..

10

MS susceptibility is not affected by single nucleotide poly..:

Nischwitz, S. ; Wolf, C. ; Andlauer, T.F.M....
Journal of Neuroimmunology. 279 (2015) - p. 46-49 , 2015

Link: https://doi.org/10.1016/..

11

Profiling of lymphocyte transcriptome changes in multiple s..:

Zettl, U.K. ; Hecker, M. ; Koczan, D....
Journal of the Neurological Sciences. 357 (2015) - p. e322-e323 , 2015

Link: https://doi.org/10.1016/..

12

Nur ein Mythos: Autismus und Multiple Sklerose nach Maserni..:

Winkelmann, Alexander ; Löbermann, M. ; Zettl, U. K.
MMW - Fortschritte der Medizin. 157 (2015) 11 - p. 47-49 , 2015

Link: https://doi.org/10.1007/..

13

Infection risks in multiple sclerosis therapy by infusion o..:

Winkelmann, A. ; Löbermann, M. ; Reisinger, E.C...
Der Nervenarzt. 86 (2015) 8 - p. 971-977 , 2015

Link: https://doi.org/10.1007/..

14

Investigation of sex-specific effects of apolipoprotein E o..:

Schrewe, L. ; Lill, C. M. ; Liu, T....
Journal of Neuroinflammation. 12 (2015) 1 - p. , 2015

Link: https://doi.org/10.1186/..

15

Multiple sclerosis treatment and infectious issues: update ..:

Winkelmann, A ; Loebermann, M ; Reisinger, E C.
Clinical and Experimental Immunology. 175 (2014) 3 - p. 425-438 , 2014

Link: https://doi.org/10.1111/..